Related Experiment Video
Updated: Jul 23, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Precise patient stratification in esophageal cancer: Biomarkers for immunochemotherapy
Shogo Kumagai1, Shohei Koyama2, Kohei Shitara3
1Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo/Kashiwa, Japan; Division of Cellular Signaling, Research Institute, National Cancer Center, Tokyo, Japan.
Abstract:
Studies have established immunochemotherapy as the first-line treatment for advanced esophageal cancer. Chen et al. and Carrol et al. performed exploratory analysis of the JUPITER-06 and LUD2015-005 trials, respectively and identified biomarkers to predict therapy response based on immunogenomic analysis. These findings may optimize precise patient stratification in advanced esophageal cancer.

